The new head NIGMS Chris Kaiser.
Patrick Gillooly / MIT
National Health fundamental research Institutes (NIH) Institute has a new director. Massachusetts Institute of Technology (MIT) cell biologist Chris Kaiser will take the $ 2 billion mark National Institute of General Medical Sciences (NIGMS) next spring.
Kaiser is now president of the MIT Department of Biology, where he uses yeast to study how proteins fold and transport molecules inside cells. He will replace the acting director NIGMS Judith Greenberg, who was filling in for Jeremy Berg left in July.
He will join the fourth largest NIH institute at a time of increasingly tight budgets. Maintaining basic R01 research grant NIGMS and the strengthening of the review process by peers are his priorities, he said Science Insider. It also plans to continue the practice of Berg blogs about how NIGMS makes funding decisions. "It is feared massive near panic in universities about getting examined subsidies and so on," says Kaiser. "It is very important, even if times become more difficult for stakeholders to understand how money is being deployed. "
Kaiser also plans to move forward with a new strategic plan for NIGMS training programs. in the implementation of the plan, it intends to draw on the lessons of the expansion, the proportion of third minority undergraduate students in the department of biology at MIT from 5% to 18% over 6 years. a key step was to reach out to mentors faculty historically minority colleges, who then suggested that their best students consider MIT for graduate school. NIGMS could seek ways to encourage these interactions, Kaiser said. "the real problem is that there are actually a huge talent pool of minority students there, but they are a step in applying for a place like MIT. "
0 Komentar